
As part of CURE®’s four-part gastrointestinal cancers webinar series, a panel of experts recently answered questions and offered advice around different types of testing.
As part of CURE®’s four-part gastrointestinal cancers webinar series, a panel of experts recently answered questions and offered advice around different types of testing.
Hear from an expert panel of health care professionals and advocates who will discuss topics for patients, survivors and caregivers on molecular precision medicine in GI cancers.
Hear from an expert panel of health care professionals and advocates who will discuss topics for patients, survivors and caregivers including diagnostic workup in GI cancers and the importance of testing.
There can be many benefits for patients with gastrointestinal cancers, as well as their loved ones, to undergo genetic testing.
An expert describes what an interventional clinical trial is.
Clinical trials are essential in improving treatment in the world of oncology, especially for rare cancers.
Now that we're in an era of personalized medicine, patients should not look at statistics and immediately think that they will determine their fate, says Tom Stockwell, patient navigator at the Fibrolamellar Cancer Foundation.
Blue Faery, the Adrienne Wilson Liver Cancer Association, is a nonprofit corporation founded in 2002, with the intent to prevent, treat and cure primary liver cancer – particularly HCC – through research, education and advocacy. Its name, inspired by Adrienne, has a unique background.
Andrea J. Wilson, president and founder of Blue Faery: The Adrienne Wilson Liver Cancer Association, offers advice for patients with liver cancer. Wilson started the foundation after her younger sister, Adrienne, died of liver cancer.
A survey about life after GI cancer has sparked the creation of specialized survivorship care plan.